Margaret A. Horn
Net Worth
Last updated:
What is Margaret A. Horn net worth?
The estimated net worth of Ms. Margaret A. Horn is at least $15,958,831 as of 16 Dec 2024. She owns shares worth $4,676,791 as insider, has earned $7,605,090 from insider trading and has received compensation worth at least $3,676,950 in Revolution Medicines, Inc..
What is the salary of Margaret A. Horn?
Ms. Margaret A. Horn salary is $735,390 per year as Chief Operating Officer, Gen. Counsel & Sec. in Revolution Medicines, Inc..
How old is Margaret A. Horn?
Ms. Margaret A. Horn is 62 years old, born in 1963.
What stocks does Margaret A. Horn currently own?
As insider, Ms. Margaret A. Horn owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | Chief Operating Officer, Gen. Counsel & Sec. | 127,991 | $36.54 | $4,676,791 |
What does Revolution Medicines, Inc. do?
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also develops RMC-5845, a selective inhibitor of SOS1, a protein that converts RAS (OFF) to RAS (ON) in cells; and RMC-5552, a hyperactivated selective inhibitor of mTORC1 signaling in tumors. In addition, the company is developing RMC-6291, a mutant-selective inhibitor of KRASG12C(ON) and NRASG12C(ON); and RMC-6236, a RAS-selective inhibitor of multiple RAS(ON) variants. Further, it develops RAS(ON) Inhibitors targeting KRASG13C(ON) and KRASG12D(ON). The company has a collaboration agreement with Sanofi for the research and development of SHP2 inhibitors, including RMC-4630. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.
Margaret A. Horn insider trading
Revolution Medicines, Inc.
Ms. Margaret A. Horn has made 35 insider trades between 2020-2024, according to the Form 4 filled with the SEC. Most recently she sold 4,329 units of RVMD stock worth $196,554 on 16 Dec 2024.
The largest trade she's ever made was exercising 57,505 units of RVMD stock on 1 Oct 2020. As of 16 Dec 2024 she still owns at least 127,991 units of RVMD stock.
Revolution Medicines key executives
Revolution Medicines, Inc. executives and other stock owners filed with the SEC:
- Dr. Mark A. Goldsmith Ph.D. (63) Chief Executive Officer, Pres & Chairman
- Dr. Stephen M. Kelsey M.D., FRCP, FRC Path. (64) Pres of R&D
- Ms. Margaret A. Horn (62) Chief Operating Officer, Gen. Counsel & Sec.